Introduction {#sec1}
============

Although rare, transmissible cancers are among the most intriguing and unexplored host-pathogen systems. The pathogens are clonal infectious malignant cell lines that originated in an individual within the host species or from a closely related species, and spread horizontally as allografts and/or xenografts. The vast majority of cancer cells that emerge in multicellular organisms die with their host, but evolutionary principles predict the existence and find cancer cell lineages that can escape the death by becoming contagious, acquire higher fitness, and consequently will be favored by selection (topic reviewed in [@bib93]). Once the cancer cells have adapted to the normal barriers that prevent host-to-host transmission, they are subject to the evolutionary dynamics of infectious agents. They are, in effect, a new parasitic "species" ([@bib24]). Currently, transmissible cancers have only been documented in three animal groups that occupy both terrestrial and marine environments and appear to result from the confluence of several environmental, host, and cell factors (the "perfect storm theory," [@bib91]). Transmissible cancers have been proposed to have existed since the transition to multicellularity ([@bib49]). The evolution of multicellular organisms required that individual cells forgo their own reproductive interests, i.e., shifting the Darwinian unit of selection from individual cells to the entire multicellular community. However, the division of labor and specialization by differentiated cells in multicellular organisms also provided opportunities for these tissues to be colonized by fast proliferating cheater cells that take advantage of the benefits of multicellular tissue (e.g., blood flow) while not performing a differentiated function. To prevent colonization, multicellular organisms evolved defense mechanisms that may include sexual reproduction ([@bib89]) ([Figure 1](#fig1){ref-type="fig"}) and the development of immune systems ([@bib50]; [@bib53]; [@bib56]).Figure 1Contagious Cancer Cells May Have Contributed to the Evolution of Sex(A) Asexual reproduction results in low genetic diversity and high inter-individual similarity within a population that can lead to increased risk of vertical and horizontal transmission of contagious cells.(B) Sexual reproduction results in greater genetic and inter-individual diversity in a population that limits the transmission probability of contagious cancer across individuals. Recognition of invading non-self cells is facilitated by higher inter-individual diversity. Selfish malignant cells regularly emerge in an organism, but unless the rare confluence of environmental and genetic factors occur ("perfect storm"), transmission of contagious cells will not occur (modified from [@bib89]).

The evolutionary importance of transmissible cancers as selective force is also demonstrated by their detectable impact on current vertebrate and invertebrate hosts. As described below, the devil facial tumor disease 1 (DFT1), previously referred to as DTFD, one of the three recognized mammalian contagious cancer lines, has caused \>85% population decline in only 20 years as the Tasmanian devil species (*Sarcophilus harrisii*), once highly abundant, has been driven to the brink of extinction ([@bib48]). Similarly, epizootic outbreaks of bivalve neoplasia have caused mass population declines in marine mollusk populations ([@bib47]). Such declines may have led to increased frequency of resistant individuals in the host population, which may have concomitantly contributed to the emergence of clonal cell lineages that are no longer able to infect the original host species, but are able to overcome immune defenses in a novel host ([@bib51]). It is also important to note that larger host population size may actually be the more likely scenario for host switching to occur. Perhaps success in one species could allow a larger population size of the cancer lineage, which might lead to a higher likelihood of a mutation that would allow a cross-species jump. An increased amount of cancer cells in the environment would provide more chances of cross-species interaction. In addition, from the literature in parasitology, other scenarios can be predicted. For example, a reduction in the host population may, at least temporarily, result in an increase in the parasite (here transmissible cancer) density ([@bib19]). Then, a high parasite density on the principal host is likely to increase the number of infective propagules in the surrounding area and hence the probability of accidental encounter (and hence use) of alternative host species ([@bib43]; [@bib65]). Also, a high parasite (here transmissible cancer) density may increase overcrowding and within-host competition for limited resources, which may also favor alternative host use ([@bib27]). Finally, the "principal host density" hypothesis suggests that when facing a decrease in the density of the principal host, parasites may colonize new host species to hedge their bets against the risk of co-extinction by reducing their dependence on a single resource ([@bib11]; [@bib40]).

Nevertheless, it is likely that this sequence has been recapitulated many times in the history of life on earth and may have contributed to extinction of the host species ([@bib59]). Thus, contagious cancers may represent an important, but so far understudied, selective force during organismal evolution, and therefore, an important component of many ecosystems ([@bib78]).

Here we provide an overview of currently recognized transmissible cancers and discuss them from an evolutionary perspective.

Currently Known Transmissible Cancers {#sec2}
=====================================

Nine independent transmissible cancers (one in dogs, two in Tasmanian devils, and six in six bivalve species) have so far been identified in the wild ([@bib93], [@bib108]).

Canine Transmissible Venereal Tumor {#sec2.1}
-----------------------------------

Canine transmissible venereal tumor (CTVT) is caused by a sexually transmitted malignant cell line that affects dogs worldwide ([@bib85]). Previous studies have proposed the cell line to be up to 11,000 years old ([@bib86]), whereas phylogenetic analyses place the time of CTVT emergence between 4,000 and 8,500 years ago ([@bib56]; [@bib55]; [@bib62]; [@bib23]; [@bib4]) and the location to Asia ([@bib4]). CTVT most commonly affects sexually active dogs, as it spreads through sexual intercourse and licking and/or biting the affected areas. The cancer is mostly localized on the external genitalia (penis and foreskin in males and vulva in females), but in rare cases it can also manifest on the face ([@bib21]; [@bib52]; [@bib63]).

Experimental transplantation studies have revealed three distinct growth phases of CTVT (1) a progressive, (2) a static, and (3) a regressive stage ([@bib21]; [@bib52]). CTVT rarely metastasizes and responds well to treatment with vincristine ([@bib57]).

Devil Facial Tumor Diseases {#sec2.2}
---------------------------

Similar to CTVT, direct contact is required for the transmission of the other two transmissible cancers in Tasmanian devils (*S. harrisii*), Tasmanian DFTDs. The first lineage of DFTD (DFT1 as some authors now refer to it) was discovered in 1996 in north eastern Tasmania ([@bib33]), whereas the second and independently risen lineage (now reffered to as DFT2) was discovered in 2014 ([@bib48]; [@bib67]) in D\'Entrecasteaux Peninsula ([Figure 2](#fig2){ref-type="fig"}). Both diseases are restricted to Tasmanian devils, which are endemic to this island, Tasmania, near the coast of Australia, and are transmitted via biting during social interactions ([@bib67]). Both diseases present as large ulcerating tumors around the face and jaws, but DFT2 tumors often spread to other parts of the body ([@bib38]). Despite the phenotypic similarity of the tumors they form, DFT1 and DFT2 cells are genetically, chromosomally, and histologically different ([@bib67]). The presence of chromosome Y in DFT2 and remnants of an X chromosome in DFT1 indicate that the older cell line emerged in a female devil and the younger from a male ([@bib54]; [@bib67]). DFT1 is a fatal cancer, frequently (70%) metastasizing to distant organs, with death typically occurring 6 to 9 months after appearance of the first lesions ([@bib68]). The typical disease course of DFT2 is not currently known. DFT1 has spread across Tasmania and reached epidemic proportion decimating the devil population, whereas DFT2 is currently confined to the D\'Entrecasteaux Peninsula.Figure 2Distribution of Devil Facial Tumor Diseases (DFT1 and DFT2)The first lineage of Tasmanian devil facial tumour diseases (previously referred to as DFTD, recently renamed as DFT1) was discovered in 1996 in the north eastern corner of Tasmania and spread across the island ([@bib33]), whereas the second and independently risen lineage, DFT2, was discovered in 2014 and is currently confined to the D\'Entrecasteaux Peninsula.

There are reports of the devils adapting to DFT1 as tumor regressions have been observed (see in details below) ([@bib28]; [@bib36]; [@bib66]; [@bib78]; [@bib107]), but the Tasmanian devil remains classified as "Endangered" by the International Union for Conservation of Nature (<https://www.iucnredlist.org/>) and may face extinction in the coming decades ([@bib48]).

Bivalve Transmissible Neoplasias {#sec2.3}
--------------------------------

Abnormal proliferation of cells in bivalve hemolymph, i.e., disseminated neoplasia (DN, also referred to as hematopoietic or hemic neoplasia), has been widely described since the 1960s from various mollusks such as clams, mussels, oysters, and cockles across the world ([@bib5]). Originally, a retrovirus or retrotransposon etiology was suspected ([@bib60]), but recent studies demonstrated the horizontal transmission of clonal cells, and thus the presence of bivalve transmissible neoplasia (BTN) in soft-shell clams (*Mya arenaria*), in mussels (*Mytilus trossulus*), and in cockles (*Cerastoderma edule*) ([@bib50], [@bib51]), with currently two lineages being recognized in the last one. BTN cells have also been able to transmit across species, i.e., in golden carpet shell clams (*Polititapes aureus*) the cancer cells originated from the pullet shell clam (*Venerupis corrugata*) ([@bib50], [@bib51]) and a cancer line in the Pacific mussel *Mytilus trossulus* has spread to two other European and Chilean mussel species, *Mytilus edulis* and *Mytilus chilensis* ([@bib108]). The distribution of transmissible BTN across continents most likely has been facilitated by a transmission mode that does not require direct contact between individuals; by human interference, e.g., the transplantation of seed stocks along the coast of the United States during the 1990s; as well as by marine transportation across the globe ([@bib51], [@bib108]).

DN and BTN are characterized in bivalves by the presence of large, invasive pleomorphic cells in the hemolymph, the circulatory fluid of bivalves. These neoplastic cells can cause displacement, compression, and necrosis within tissues due to disturbed apoptosis and phagocytic abilities ([@bib1]). Neoplastic hemocytes in bivalves are also often aneuploid with an increased DNA content indicating a relative high chromosomal instability ([@bib9]). In addition, diseased cells lose their phagocytic abilities, express a novel surface antigen, and display cytoplasmic sequestration of the TP53 tumor suppressor protein ([@bib103]). Possible physiological effects of the disease include tissue emaciation, pale digestive gland, gonadal atrophy, and mantle recession ([@bib20]), suggesting nutritional stress, reduced energy intake, or a possible metabolic burden imposed by the neoplastic cells on the host ([@bib5]). As the disease is progressive, it often results in the death of the individual. Neoplastic diseases in bivalves appear at their highest frequency in polluted areas with high levels of heavy metals, polychlorinated biphenyls, and polycyclic aromatic hydrocarbons ([@bib13]).

Transmissible Cancers: the Inter-individual Metastasis {#sec3}
======================================================

Many cancers are directly or indirectly caused by infectious agents ([@bib2]; [@bib100]; [@bib101]; [@bib22]; [@bib29]), but for a cancer to be truly horizontally transmissible, the cancer cell itself must be able to migrate between hosts. The transplantation of live tumor cells (but not killed cells or filtrates) between individuals and the presence of characteristic marker chromosomes and cancer-specific genotypes in all tumor samples collected from different host populations across geographic regions provide evidence that the cancer cells are indeed transmitting as allografts.

The fitness of non-transmissible cancer cells is primarily determined by their capacity to proliferate, avoid immune recognition, undergo clonal expansion, and metastasize to novel organs to avoid competition at the primary tumor site. However, their survival is ultimately limited by the lifespan of the host. Cells that can persist in the host population by escaping the original host before its death will occupy an empty niche, and thus acquire higher fitness.

Similar to the metastatic cascade of classical cancers, the spread of a transmissible cancer to a new host is a multi-step biological process in which the cancer cells must overcome distinct barriers and obstacles ([@bib31]; [@bib95]) ([Figure 3](#fig3){ref-type="fig"}). Following the initial growth at the primary tumor sites ([@bib58]), cancer cells acquire the capacity to disassemble the extracellular matrix and intravasate the lymphatic or blood microvessels, and to disseminate throughout the body of the host (i.e., metastasize). Although most of those circulating cells will die, some are able to survive transit by arresting in the capillary beds within distant organs and extravasate into the new host tissue ([@bib58]; [@bib32]). Following extravasation, the majority of invading cells perishes, and only a very small minority of metastatic cells ultimately colonize the new tissue site and form a clinically apparent tumor ([@bib58]).Figure 3Population Biology of Intra- and Inter-individual MetastasisThe generalized steps necessary for cancer cells to transmit to a new host are analogous to the steps of intra-individual metastasis (modified from [@bib15]). Similar to the classical metastatic cascade, following the initial growth at the primary tumor site, transmissible cancer cells have to survive transit, colonize, and establish in the new microenvironment of the novel host.

However, the total life cycle of a transmissible cancer is also affected by the evolutionary dynamics of infectious agents in which virulence and infectivity trade-offs are common. Most simply, the virulence of the disease cannot be so great that the host will not survive to transmit the disease. In the devil facial tumor, for example, the infected host can transmit the disease only if there are other devils in its territory, if the host is sufficiently healthy to socially interact with other devils, and if the inoculum of cancer cells during that interaction is sufficient to cause tumor formation in the new host. These are all highly dynamic variables. For example, as the tumor spreads throughout a population, the density of available, uninfected partners can decrease. If the tumor kills the host too quickly it may become too debilitated to perform the biting necessary to transmit the disease. Furthermore, if there is selection for resistance over time, the required inoculum size may increase substantially. Proliferative immortality (that is, for example, permitted by the continuous replenishment of chromosome ends via upregulated telomerase activity in DFT1 and CTVT, [@bib17]; [@bib98]) and the capacity for self-renewal allow the existence of these clonal cell lines.

Clearly, a key factor in these dynamics is the barriers for tumor transmission. Perhaps the most obvious of these include histocompatibility barriers (i.e., self/non-self recognition, not only within individuals of a species but also across species), as demonstrated by the mammalian tumors (CTVT and DFTDs) that have been proposed to have emerged due to the low genetic diversity of the host species (reviewed in [@bib7]).

However, the transmitted cancer cells may also be limited by foreign environments that lack growth factors and nutrients and are subject to a host of immunological and non-immunologic host responses. Furthermore, contagious cancers must be transmitted by direct contact (DFTDs, CTVT) or environmental transport (BTN). This requires time outside of the host and tolerance to non-physiological conditions ([@bib104]). For example, because bivalves are filter feeders, BTN likely spreads through seawater. BTN cells therefore must be tolerant to a wide range of changes in the physical properties (e.g., temperature) and soluble factors within seawater. Indeed, bivalve neoplastic cells have been shown to survive at least 6 h under the broad range of environmental conditions encountered in marine habitats occupied by bivalve populations (i.e., variations of salinity, temperature, dissolved oxygen concentration, and pH on a diel temporal scale). Neoplastic cells of bivalves are able to survive typical estuarine conditions (salinity of 15, temperature of 24°C) for at least 48 h, and some cells are even able to remain viable in freezing conditions ([@bib88]).

How Transmissible Cancers Emerge: The Perfect Storm Theory {#sec4}
==========================================================

Although contagious cancer cells gain a clear fitness advantage over non-transmissible cell lines, the substantial barriers to horizontal transmission of cancer cells require a "perfect storm" with the confluence of multiple host (micro- and macro-environmental factors) and tumor cell traits ([@bib91]).

Propagule Pressure, Permissive Environments, and Phenotypic Plasticity Facilitate Cancer Cell Transmission {#sec4.1}
----------------------------------------------------------------------------------------------------------

Conditions that are necessary for direct passage of cancer cells between hosts include tumor tissue properties that promote shedding of large numbers of malignant cells, some interactions between hosts that allow transmission, tumor cell (genetic and phenotypic) plasticity that permits survival during transmission and establishment in a new host, and a "permissible" host or host tissue.

Investigations of colonizing events by non-native species has found that outcomes depend on the "propagule pressure," i.e., (1) the number of cells shed at introduction, (2) the number of introduction events, (3) and the temporal and spatial patterns of propagule arrival ([@bib91]).

Similar dynamics have been observed in cancer spread. For example, in the formation of metastatic disease from a primary site in the same host, the loss of cells at each step in the metastatic cascade is so substantial that no more than 1 cell in 10,000 will form a metastasis ([@bib14]). Similarly, in inter-individual metastatic cancers, the tumor inoculum needs to be very high ([@bib6]; [@bib42]). In DFT1, for example, under laboratory conditions, 10^5^ to 10^6^ DFT1 cells in immunocompromised mice are necessary for tumor formation ([@bib41]). Experimental transmission of BTN showed that injecting 10^6^ BTN cells induced cancer in 33% new hosts, whereas injecting 10^7^ BTN cells resulted in 50% infection rate ([@bib34]).

Establishment in, and adaptation to, a hostile host environment is governed by genetic similarity of the hosts, by the hosts\' immune competence, and direct competition between cells from the host and cells from the cancer ([@bib82]). Contributing to host immune response, histocompatibility barriers generally prevent the transplantation of foreign grafts between individuals, or between species. The ability of DFT1 to infect \>150,000 members of the same species has been attributed to the low genetic diversity of the Tasmanian devils ([@bib7], [@bib8]). In addition, DFT1 cancer cells use epigenetic immune modulation to down-regulate genes involved in the antigen-processing pathways. This loss of cell surface expression of self/non-self recognizing major histocompatibility complex class I (MHC) molecules results in immune recognition evasion ([@bib82]; [@bib83]). Interestingly, the more recently emerged DFT2 cells have evolved a different immune escape strategy by expressing MHC alleles that are shared with hosts carrying tumors ([@bib12]).

The mechanism(s) by which CTVT evades the host immune system are not completely known. However, experimental transplantation studies find that CTVT cancer cells initially secrete transforming growth factor β (TGF-β) that suppresses class I and II dog leukocyte antigen expression (DLA, equivalent of dog MHC) and natural killer cell activity. Tumor-infiltrating leukocytes produce interleukin-6 (IL-6) that counteracts, and eventually overcomes TGF-β, leading to the re-expression of DLAs on CTVT cells and finally to the elimination of tumor cells ([@bib16]; [@bib35]). Importantly, during CTVT regression, most upregulated genes appeared to be of host origin and [@bib30] proposed that the immune response to CTVT tumors was driven by a critical epigenetic remodeling of host tissue surrounding the tumor cells.

Epigenetic regulation, and thus phenotypic plasticity (change in phenotypic expression in response to environmental variations) not only facilitates immune system evasion but also can be essential facilitators for cancer cells to adapt to a range of environmental conditions both in transit and in the hosts ([@bib91], [@bib92]). For example, phenotypic plasticity has been observed in the recently emerged DFT2 tumors, some expressing MHC class I molecules that are either shared with host devils or are non-classical MHC molecules, whereas in other DFT2 tumors the loss of MHC class I expression has been observed ([@bib12]). Changes in epigenetic marks have been associated with the emergence and evolution of DFT1 cancer cells ([@bib37]; [@bib96]). Disintegration of a hypermethylated X chromosome followed by increasing loss of methylation of the DFT1 genome suggest that DFT1 is a dynamically changing entity with a high phenotypic plasticity and evolutionary potential ([@bib96], [@bib95]). Although variation in mollusk methylome has already been demonstrated (e.g., during ontogenesis or in response to environmental stressors), it is still unknown whether epigenetic variation contributes to phenotypic plasticity in DN and BTN ([@bib75]).

Environmental Factors and Instable Genomes May Contribute to the Emergence of Transmissible Cancers {#sec4.2}
---------------------------------------------------------------------------------------------------

Little is known about the origins and critical factors initiating transmissible cancers in nature. Although CTVT is the oldest known transmissible cancer cell lineage, its cellular origin remains uncertain. Various studies suggest a macrophage or a myeloid origin (reviewed in ([@bib21]; [@bib52])), whereas the latest transcriptomic analysis proposed a skin cancer and cutaneous melanoma origin ([@bib30]). DFT1 and DFT2 appear to have both originated from cells of the peripheral nervous system ([@bib84]; [@bib64]). As melanoma and devil facial tumor cells are both proposed to have derived from neural crest cells, [@bib30]) have recently suggested that some transmissible cancers may share a common origin.

A combination of environmental factors and unstable genomes has been implicated in all three types of transmissible cancers. DFT1 and CTVT both carry the mutational signature of solar UV radiation ([@bib23]; [@bib54], [@bib55]; [@bib84]). Most bivalves are intertidal species, and hence are exposed to UV radiation ([@bib79]). Thus, it is feasible that UV exposure might have been a key initiator in all the known contagious cancers. Indeed, [@bib4]) have observed non-linear association between latitude and UV exposure and consequently location-specific variations in the mutational spectra of CTVT. In addition, bivalve neoplastic diseases appear at their highest frequency in heavily polluted areas (with heavy metals, polychlorinated biphenyls, and polycyclic aromatic hydrocarbons) ([@bib13]), which may have also contributed to genome instability and consequently genetic mutations facilitating abnormal cell proliferation.

Tug of War: Evolution of Transmissible Cancers and Their Hosts {#sec5}
==============================================================

Hosts Can Resist or Tolerate the Challenges by Contagious Cell Lines {#sec5.1}
--------------------------------------------------------------------

Similar to classical pathogens, and in contrast to classical cancer cells, transmissible cancer cell lines have emerged from a common ancestor, maintaining their malignant genotypes and phenotypes across generations in the hosts\' population. Therefore, their evolution follows fundamental Darwinian principles and resembles host-parasite interactions (described by the "Red-Queen" dynamics [@bib99]; [@bib81]). As transmissible cancers negatively affect host fitness, by either impeding reproductive output (CTVT) or reducing survival (DFTD and BTN), they also impose strong selection pressure for resistance.

When infected by a pathogen, hosts can evolve defensive responses that can be broadly categorized as (1) resistance, defined as the ability of a host to limit or inhibit pathogen replication, thus reducing infection severity, and (2) tolerance, defined as the ability of an infected host to limit the impact of infection on host fitness ([@bib70]; [@bib76]). When relying on resistance, a host can employ a multitude of, often costly, behavioral, morphological, physiological, and/or immunological defense mechanisms to limit and eliminate the negative effects of the pathogens ([@bib69]; [@bib70]; [@bib76]). Unlike resistance, host tolerance does not limit infection, but reduces or compensates parasite-induced damages through reduced immunopathology, increased wound repair mechanisms, and a greater resilience to tissue injuries ([@bib69]; [@bib70]; [@bib76]). Tolerance thus offsets and/or reduces the pathogen\'s impact at significantly lower fitness costs compared with responses involving resistance ([@bib69]; [@bib70]; [@bib76]). Although resistance and tolerance may result in similar fitness benefit for the host, their evolutionary arcs proceed in different directions. That is, resistance produces a negative feedback loop by eventually eliminating the host alleles from the population that initially provided resistance against the infection (as the pathogen evolves faster and the host alleles that initially provided resistance become redundant over time), whereas tolerance generates a positive feedback loop that increases the chance for "tolerance genes" becoming fixed in the host population ([@bib44]; [@bib69]; [@bib70]; [@bib76]). As both tolerance and resistance are epidemiologically and ecologically costly ([@bib73]), selection will therefore favor the most cost-effective strategy (resistance, tolerance, or the combination of the two) ([@bib73]). Indeed, the combination of the two strategies has been observed in Tasmanian devil populations. Several studies have now shown rapid phenotypic and genetic adaptations to DFTD ([@bib78]) including changes in reproductive strategy (transitioned from multiple reproductive cycles to a single breeding pattern, [@bib39], in gene expression variation ([@bib94]) and in allele frequency variation at immune and tumor suppressor genes that are involved in limiting tumor growth ([@bib28]; [@bib107]) as well as genes underlying behavioral patterns ([@bib36]), which could potentially limit disease transmission. In some devil populations active immune responses and even tumor regression have been observed ([@bib66]; [@bib90]), whereas in other populations tolerance has been detected in response to DFTD ([@bib77]). Thus the extreme selection pressure imposed by DFTD has allowed the Tasmanian devil population to evolve both resistance and tolerance responses in only four to six generations ([@bib78]).

However, the transmissible cancer can also evolve adaptations to the host responses forming an "evolutionary arms race." For example, the study by [@bib23]) identified signatures of continuous adaptation by CTVT to its host, observing adaptive mutations in response to every increase in immune responses, including immune surveillance, self-antigen presentation, and apoptosis. Although spontaneous regression is uncommon in CTVT, dogs are able to tolerate the disease, and it appears that CTVT and the host have reached a stable evolutionary dynamic ([@bib71]). Nevertheless, CTVT responds to a single dose of vincristine, and [@bib30]) proposed that "CTVT is particularly susceptible to changes that break tolerance to this cancer."

Intriguingly, although invertebrates, including mollusks, do not possess MHC molecules, they are equipped with potent self/non-self recognition mechanisms ([@bib3]). Mollusks are able to respond to transplants ([@bib105]) and, in some cases, combat transformed malignant cells ([@bib74]; [@bib102]). For example, although DN can be fatal, up to 20% remission has been observed ([@bib10]). Another study in the mussel (*M. edulis*) and clam (*Mya arenaria*) also showed that the hosts were capable of developing a response against the disease, resulting in a temporary remission ([@bib26]; [@bib106]). These studies indicate the presence of a thus far unknown immune response to DN cells, as well as potentially against BTN cells, and the ability of mussels to resist neoplasia.

The Evolution of Transmissible Cancer Cell Lines in Response to Challenges by the Host {#sec6}
======================================================================================

Escaping the Red-Queen by Crossing the Species Barrier {#sec6.1}
------------------------------------------------------

Both CTVT and BTN can cross histocompatibility barriers between members of the same species and even between species. For example, jackals ([@bib80]) and coyotes ([@bib18]) have been experimentally transfected with CTVT (reviewed in [@bib52]), and cross-species transmission of BTN has been observed between two sympatric mollusks belonging to the same family (*Veneridae*) ([@bib51]), as well as between mollusk species across continents ([@bib108]) (see earlier discussion). The ability of infectious cancers to transmit across species suggests two interesting evolutionary scenarios: (1) the original hosts have been able to recognize and evolve resistance against their own cells and (2) the cancer cells have potentially been able to overcome host resistance (thus "outrun the Red-Queen") by spreading to a novel host species.

Intra- versus Inter-individual Metastasis: Where Should Evolution Take Transmissible Cancers {#sec6.2}
--------------------------------------------------------------------------------------------

Transmissible cancers, in effect, are an inter-individual metastasis, and this poses fascinating evolutionary questions. In an infectious cancer, one might reasonably expect that higher proliferation rate and enhanced capacity to spread to different organs would favor a higher level of infectivity, and thus increased fitness of the cancer population. However, these same properties will also promote more rapid metastatic spread in the host leading to a more virulent cancer, which could lead to host disability or death before successful transmission. This would reduce the fitness of the cancer population. Consequently, a strategy that allows efficient inter-individual transmission and also reduced impact on host organs (thus prevention of intra-individual spread) may provide the highest fitness outcome to contagious cancer cell lines. As intra- and inter-individual metastasis might be driven by potentially similar mechanisms, deciphering the evolutionary trajectory of these intriguing parasitic cell lines remains a challenging but fascinating topic of evolutionary biology.

Transmissible Cancer Cell Lines Survive over Evolutionary Time by Overcoming Genomic Decay {#sec6.3}
------------------------------------------------------------------------------------------

As transmissible cancer cell lines have emerged and evolved from one ancestral cell, they propagate by asexual reproduction resulting in accumulation of deleterious mutations (termed "Muller\'s ratchet\") leading to a decline in fitness. However, CTVT has been shown to avoid an "information catastrophe" ([@bib25]) by capturing and incorporating host mitochondrial DNA (mtDNA) ([@bib72]), as well as via negative selection in captured mtDNA and occasional mtDNA recombination and re-assortment ([@bib87]). Although more work is needed to confirm mitochondrial replacement in bivalves, the sequence data from some of the Chilean BTN samples indicated the replacement of part of the cancer mtDNA genome with sequence from the host mtDNA ([@bib108]). However, host mtDNA capture has not been observed in the DFTDs perhaps because the diseases are, evolutionarily speaking, relatively young and may not yet be subject to Muller\'s ratchet. More likely, DFTDs employ other mechanisms, such as increasing chromosome numbers or duplication associated with ectopic gene conversion to overcome genomic decay ([@bib45]). The increased ploidy can stabilize the genomic configuration of clonal cells and hence promote the selection of polyploid cancer cells, which are also able to sustain higher mutation rates. Polyploidy can therefore mask recessive deleterious mutations and ameliorate genomic decay ([@bib61]). As elevated chromosome numbers have been observed in all transmissible cancers, polyploidy may provide an adaptive advantage ([@bib50]; [@bib52]; [@bib97]). Positive selection has been shown to outweigh negative selection during the evolution of classical, non-transmissible cancer development ([@bib46]). The lack of negative selection on coding (potentially fatal) point mutations in clonal cancer cells indicates that either the majority of genes are dispensable in these cell lineages or that the deleterious effect is being buffered by diploidy/polyploidy and/or by the inherent resilience and redundancy of cellular pathways ([@bib46]). This could also explain the capacity of long-lived transmissible cancer cell lines, such as CTVT, to accumulate and tolerate extreme levels of hypermutation ([@bib4]; [@bib54], [@bib55]). In a recent study, [@bib4] found that in contrast to short-lived cancers where positive selection is the primary driving force, neutral genetic drift appears be the dominant evolutionary force operating in CTVT (but see [@bib23]). As discussed earlier in the article, the lack of negative selection may result in the accumulation of deleterious mutations; however, the increased chromosome numbers in cancer cells most likely buffer the effect of negative selection and facilitate the maintenance of cancer cells\' fitness.

Conclusions {#sec6.4}
-----------

""Just like people often don\'t realize the benefits of vaccines when the disease becomes rare, evolutionary biologists may not recognize the critical role of transmissible cancers in shaping animal evolution as these cancers are very rare \[Prof James DeGregori\]"."

So far there are very few infectious cancer clones described. This could be due to several factors: (1) we just have not looked hard enough, (2) they did exist but their hosts were driven to extinction, and (3) they are exceedingly rare because "perfect storms" are rare, i.e., the barriers are very stringent. Although transmissible cancers appear to be rare in nature, they represent a fascinating and important eco-evolutionary phenomenon that may provide novel insights into human cancers. It is likely that during the history of life on earth, several contagious cancers have evolved on numerous occasions and may have contributed to some species extinctions. Similar to classical host-parasite interactions (described by the "Red-Queen" dynamics ([@bib99]; [@bib81])), both hosts and contagious cancer cells will evolve continuously to adapt to their opponent\'s innovations generating an evolutionary arms race. These strategies and counterstrategies may be recapitulated over time as the tumor-host interactions progress from *in situ* growth to progression at the primary site to elements of the metastatic cascade.

Limitations of the Study {#sec6.5}
------------------------
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